ArticleThe Lancet. Haematology2022

Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.

Habib El-Khoury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.